DLHAX
Price
$24.99
Change
-$0.01 (-0.04%)
Updated
Feb 21 closing price
Net Assets
742.87M
FSPHX
Price
$27.96
Change
-$0.57 (-2.00%)
Updated
Feb 21 closing price
Net Assets
7.05B
Ad is loading...

DLHAX vs FSPHX

Header iconDLHAX vs FSPHX Comparison
Open Charts DLHAX vs FSPHXBanner chart's image
Macquarie Healthcare A
Price$24.99
Change-$0.01 (-0.04%)
VolumeN/A
Net Assets742.87M
Fidelity Select Health Care
Price$27.96
Change-$0.57 (-2.00%)
VolumeN/A
Net Assets7.05B
DLHAX vs FSPHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DLHAX vs. FSPHX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLHAX is a Buy and FSPHX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSPHX has more cash in the bank: 7.05B vs. DLHAX (743M). DLHAX pays higher dividends than FSPHX: DLHAX (0.51) vs FSPHX (0.00). DLHAX was incepted earlier than FSPHX: DLHAX (17 years) vs FSPHX (44 years). FSPHX is a more actively managed with annual turnover of: 40.00 vs. DLHAX (3.00). FSPHX has a lower initial minimum investment than DLHAX: FSPHX (0) vs DLHAX (1000). FSPHX (-6.17) and DLHAX (-6.18) have marching annual gain over last year. FSPHX return over 5 years is better than : -3.30 vs. DLHAX (-6.45).
DLHAXFSPHXDLHAX / FSPHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years44 years-
Gain YTD5.0534.661108%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets743M7.05B11%
Annual Yield % from dividends0.510.00-
Returns for 1 year-6.18-6.17100%
Returns for 3 years-3.114.14-75%
Returns for 5 years-6.45-3.30196%
Returns for 10 years29.7221.49138%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMRFX58.53N/A
N/A
American Funds American Mutual F2
IAMOX3.41N/A
N/A
Voya MidCap Opportunities Port A
TGWTX14.70N/A
N/A
Transamerica Large Growth I3
GSDPX49.15N/A
N/A
Goldman Sachs US Tax-Managed Eq P
LFGQX38.59N/A
N/A
Lord Abbett Focused Growth R3